Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
Eradivir Closes $10M Private Financing
Growth StageVenture Capital

Eradivir Closes $10M Private Financing

P
Pulse
•October 7, 2025
P
Pulse•Oct 7, 2025
0

Participants

Eradivir

Eradivir

company

Deal Summary

Eradivir, a clinical-stage biotechnology company, closed a $10 million private financing round to support its immune‑based therapeutic development. The round was announced on 2025-10-07; no investors were disclosed in the release.

0

Comments

Want to join the conversation?

Loading comments...